SBIR/STTR Research Award

Oscillating Magnetic Field Assisted Supercooling Preservation of Fresh and Unfrozen Ovaries at Subzero Temperatures

Award identifier 06af24e4502c859a5f3bae551b04954447492a47fad08c24c4bd838ab30e77b8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$275,001

Program and phase

SBIR · Phase I

Award year

2023

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
JUN INNOVATIONS INC
Proposal award date
2023-09-25
Contract end date
2024-08-31
UEI
JNW8AQVY4633
Solicitation number
PA22-176
Topic code
NICHD

Research abstract

PROJECT SUMMARY/ABSTRACT When the internal temperature of a material during freezing is below its equilibrium freezing point before ice nucleation has occurred, the material is said to be in the supercooled state. The long-term objective of this project is to develop a novel commercially viable supercooling device to preserve biological materials far below their freezing points while retaining their functionalities live. Engineered magnetic fields in the oscillation mode has been proved to control the discharge and realignment of water molecules using diamagnetic properties of water molecules. Therefore, water in biological materials can remain unfrozen at subzero temperatures when magnetic fields are applied. Among many other materials for cryopreservation and organ banking, we have selected the whole mice ovary for our focused proof of concept. The developed supercooling technology will enable an extended storage duration as well as higher recovery rates of ovarian functionalities with zero toxicity, compared to classic cryopreservation methods. In the Phase I study, the supercooling technology will be tested for an extended supercooling status of mice ovaries at -5 to -10 °C for up to 4 weeks, and their preserved fertilities will be examined. We anticipate a robust and stabilized solution for hypothermic yet non-freezing preservation of diverse biological samples, i.e. cells, tissues, and organs, by extension. In the past several years, a number of studies have appeared questioning the functional qualities of biological materials stored using conventional cryopreservation methods. They indicated that (i) biological systems have highly organized structures that are extremely sensitive to freezing/thawing processes and (ii) high concentrations of cryoprotective agents (CPAs) such as dimethyl sulfoxide (DMSO) are potentially toxic. When the biological sample is cooled below its melting point, or equilibrium freezing temperature, water within the cellular structure will undergo a phase change from liquid to solid. The formation of extracellular ice is known to be a hazard to structured tissues and organs. In addition, DMSO shows high cytotoxicity and affects the differentiation of neuron-like cells, cardiac myocytes, and granulocytes, and needs to be eliminated rapidly after thawing. The developed technique will offer the technical feasibility and solid foundations for any full-organ or complex tissue preservation efforts, providing insight into potential structural and functional effects of the preservation process on high-content, complex and human-derived organs.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

5 SBIR/STTR records share this UEI (2016–2025). Reported award amounts total $1,246,061. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Agriculture, Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.